Approximately 15% of breast cancers that are hormone receptor-positive and 5% of the more dangerous triple-negative breast cancers have been shown to have FGFR-1 overexpression, which is reported as frequent in breast cancer [1,2,3,4,5]. This evidence concerns the gene NR4A1 and breast cancer.